Ascend Wellness Holdings, Inc. (AAWH) research
Ascend Wellness Holdings, Inc.- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Last price
- $0.55
- As of
Ascend Wellness Holdings, Inc. (AAWH): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-31.
As of . Source: SEC EDGAR filings for AAWH. Method and limitations.
Share the AAWH intelligence card
See the full AAWH dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for AAWH on one page. Preview it with sample data, then open it live with a free account.
Preview the AAWH dossierActive signals for AAWH
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 45.0%, EPS $-0.05 vs $-0.0909 estimate
- mediumEARNINGS_MISS
Q2-2025: Missed consensus by 58.3% - EPS $-0.12 vs $-0.0758 estimate
- mediumEARNINGS_MISS
Q3-2025: Missed consensus by 43.0% - EPS $-0.13 vs $-0.0909 estimate
- mediumEARNINGS_MISS
Q4-2025: Missed consensus by 106.5% - EPS $-0.24 vs $-0.1162 estimate
- mediumEARNINGS_MISS
Q1-2026: Missed consensus by 27.3% - EPS $-0.15 vs $-0.1178 estimate
FREE, NO ACCOUNT
Every signal on AAWH, as it fires
New filings, 13F moves and cross asset signals on AAWH land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, AAWH
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
AAWH against its peers
AAWH's operating margin of -3.4% ranks in the 66th percentile of 15 Drug Manufacturers - Specialty & Generic sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-06-30.
| Metric | AAWH | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 501M USD | 49.9M USD | 92 | 17 |
| Gross margin | 33.9% | 43.4% | 32 | 10 |
| Operating margin | -3.4% | -13.3% | 66 | 15 |
| Net margin | -23.6% | -36.5% | 62 | 16 |
| Return on equity | n/a | -28.3% | n/a | 14 |
Peers (18): CPIX, GRUSF, BGM, ADCT, TSNDF, JUSHF, CRDL, CWBHF, DERM, TLPH, ZYBT, CRLBF, AKBA, LEEEF, ELTP, SCYX, PLNH, IXHL. Left out: CTOR (no annual filing), OGI (period gap), ASRT (no annual filing), INCR (period gap), PHBI (period gap), LFCR (no annual filing), GSTK (no annual filing). Fiscal periods ending between 2025-09-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (AAWH: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more AAWH signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to AAWHand get the insider, 13F, options, and confluence read in one view.